Career history of William Rapeport
Former positions of William Rapeport
| Companies | Position | Start | End |
|---|---|---|---|
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Director/Board Member | 2007-03-22 | 2019-12-18 |
| Chief Executive Officer | 2007-03-22 | 2019-12-18 | |
| Chief Tech/Sci/R&D Officer | 2007-03-22 | 2019-12-18 | |
| Founder | 2007-03-22 | 2019-12-18 | |
| GALAPAGOS NV | Director/Board Member | 2009-07-05 | 2010-06-29 |
| GSK PLC | Corporate Officer/Principal | - | - |
| Glaxo Wellcome Plc | Corporate Officer/Principal | 1995-12-31 | - |
| PFIZER, INC. | Corporate Officer/Principal | 1987-12-31 | - |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Director/Board Member | 2006-10-31 | - |
| Chief Executive Officer | 2006-10-31 | - | |
| Founder | 2006-10-31 | - |
Training of William Rapeport
| University of Glasgow | Undergraduate Degree |
| University of Oxford | Undergraduate Degree |
Statistics
International
| United Kingdom | 7 |
| Belgium | 2 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GALAPAGOS NV | Health Technology |
| PFIZER, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
RespiVert Ltd.
RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Distribution Services |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
- Stock Market
- Insiders
- William Rapeport
- Experience
